OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Genomics
(28)
Organisms
Homo sapiens
(28)
Repository
EGA
(28)
Technology Type
Illumina 15K
(8)
Illumina Human 1.2M Duo custom BeadChips v1 - Genome Studio, Illumina Human 660K Quad BeadChips - Illuminus, Illumina Human-Ref 8 v3.0 expression array
(1)
Illumina 1.2M, Affymetrix 6.0, Affymetrix 6.0 - CHIAMO
(1)
Illumina 1.2M, Affymetrix 6.0
(1)
Affymetrix 6.0
(1)
Illumina HumanExome-12v1_A-GenCall, zCall, GenoSNP, - Illuminus
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Cardiogenics_24K - samples
Cambridge control samples using a 24k expression array from Illumina
EGAD00010000389
|
EGA
Cite
Cardiogenics_660K - samples
Cambridge control samples using a 660K genotyping chip from Illumina
EGAD00010000391
|
EGA
Cite
Cardiogenics_1.2M - samples
Cambridge control samples using a 1.2M genotyping chip from Illumina
EGAD00010000387
|
EGA
Cite
Powerful Identification of Cis-regulatory SNPs in Human Primary Monocytes Using Allele-Specific Gene Expression
The aim of this study was to compare the power to detect associations between SNPs using cis-eQTL mapping and ASE analysis (allele specific expression).
EGAS00000000119
|
EGA
Cite
ASE vs GTE Study Data Access Committee
Data Access Committee EGAC01000000019
EGAC01000000019
|
EGA
Cite
PR
Pharmacogenomic response to Statins samples (Genotypes/Phenotypes)
EGAD00010000282
|
EGA
Cite
58BC - samples
WTCCC2 samples from 1958 British Birth Cohort
EGAD00010000234
|
EGA
Cite
T2D - samples
WTCCC2 samples from Type 2 Diabetes Cohort
EGAD00010000232
|
EGA
Cite
HT - samples
WTCCC2 samples from Hypertension Cohort
EGAD00010000230
|
EGA
Cite
CAD - samples
WTCCC2 samples from Coronary Artery Disease Cohort
EGAD00010000236
|
EGA
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets